Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Anastasia S. Suraev"'
Autor:
Danielle McCartney, Richard C. Kevin, Anastasia S. Suraev, Ayshe Sahinovic, Peter T. Doohan, Miguel A. Bedoya‐Pérez, Ronald R. Grunstein, Camilla M. Hoyos, Iain S. McGregor
Publikováno v:
Drug Testing and Analysis. 15:334-344
A growing number of clinical trials (CTs) are investigating the therapeutic potential of cannabidiol (CBD), a non-intoxicating phytocannabinoid found in Cannabis sativa. These CTs often use crossover experimental designs requiring 'washout' (clearanc
Autor:
Danielle McCartney, Anastasia S Suraev, Peter T Doohan, Christopher Irwin, Richard C Kevin, Ronald R Grunstein, Camilla M Hoyos, Iain S McGregor
Publikováno v:
Journal of Psychopharmacology. 36:1338-1349
Background: Cannabidiol (CBD), a major cannabinoid of Cannabis sativa, is widely consumed in prescription and non-prescription products. While CBD is generally considered ‘non-intoxicating’, its effects on safety-sensitive tasks are still under s
Autor:
Ronald R. Grunstein, Danielle McCartney, Iain S. McGregor, Camilla M. Hoyos, Richard C. Kevin, Christopher Irwin, Anastasia S. Suraev
Publikováno v:
Drug Testing and Analysis. 14:137-143
Many jurisdictions use point-of-collection (POC) oral fluid testing devices to identify driving under the influence of cannabis, indexed by the presence of Δ9 -tetrahydrocannabinol (THC), an intoxicating cannabinoid, in oral fluid. While use of the
Autor:
Danielle, McCartney, Richard C, Kevin, Anastasia S, Suraev, Christopher, Irwin, Ronald R, Grunstein, Camilla M, Hoyos, Iain S, McGregor
Publikováno v:
Drug testing and analysis. 14(1)
Many jurisdictions use point-of-collection (POC) oral fluid testing devices to identify driving under the influence of cannabis, indexed by the presence of Δ
Autor:
Ronald R. Grunstein, Camilla M. Hoyos, Christopher Irwin, Anastasia S. Suraev, Danielle McCartney, Iain S. McGregor, Melissa J. Benson, Thomas R. Arkell
Publikováno v:
Human Psychopharmacology: Clinical and Experimental. 35
Objective Interest in the use of cannabidiol (CBD) is increasing worldwide as its therapeutic effects are established and legal restrictions moderated. Unlike Δ9 -tetrahydrocannabinol (Δ9 -THC), CBD does not appear to cause cognitive or psychomotor
Autor:
Danielle McCartney, Ben Desbrow, Christopher Irwin, Anastasia S. Suraev, Iain S. McGregor, Melissa J. Benson
Publikováno v:
Sports Medicine-Open
Cannabidiol (CBD) is a non-intoxicating cannabinoid derived from Cannabis sativa. CBD initially drew scientific interest due to its anticonvulsant properties but increasing evidence of other therapeutic effects has attracted the attention of addition
Autor:
Angela L. D'Rozario, Camilla M. Hoyos, Anastasia S. Suraev, Jonathon C. Arnold, Brendon J. Yee, Christopher J. Gordon, Christopher Irwin, Iain S. McGregor, Ronald R. Grunstein, Delwyn J. Bartlett, Keith Wong, Ryan Vandrey, Nathaniel S. Marshall
Publikováno v:
BMJ Open, Vol 10, Iss 5 (2020)
IntroductionInsomnia is a highly prevalent and costly condition that is associated with increased health risks and healthcare utilisation. Anecdotally, cannabis use is frequently reported by consumers to promote sleep. However, there is limited resea
Autor:
Crispin Corte, Anastasia S. Suraev, Susan J. Connor, Sarah V. Abelev, Lucy K Gold, Iain S. McGregor, Melissa J. Benson, Lewis J. Martin
Publikováno v:
Crohn's & Colitis 360. 2
Background Medicinal cannabis (MC) is an increasingly utilized treatment option for various refractory diseases. While robust clinical evidence supporting MC efficacy in inflammatory bowel disease (IBD) is lacking, many IBD patients report using MC t
Autor:
Jonathon C. Arnold, Llewellyn Mills, Iain S. McGregor, Anastasia S. Suraev, Nicholas Lintzeris, Thomas R. Arkell, Melissa J. Benson, Maria Bravo
Publikováno v:
Harm Reduction Journal
Harm Reduction Journal, Vol 17, Iss 1, Pp 1-12 (2020)
Harm Reduction Journal, Vol 17, Iss 1, Pp 1-12 (2020)
Background In 2016, the Australian federal government passed legislation enabling a range of cannabis-based products to be prescribed to patients by registered healthcare professionals. An online survey conducted immediately prior to these legislativ
Autor:
Anastasia S. Suraev, Janice Russell, Jordyn Stuart, Jessica Booth, Iain S. McGregor, Alice Kesby, Glenn E. Hunt, Sarah Maguire
Publikováno v:
Psychoneuroendocrinology. 87:83-92
Background Nutritional rehabilitation in anorexia nervosa (AN) is impeded by fear of food, eating and change leading to treatment resistance. Oxytocin (OT) exerts prosocial effects and modulates trust, fear, anxiety and neuroplasticity. The current p